Michel Ferreira Machado
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Michel Ferreira Machado has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Ricardo Nitrini
Department of Neurology, Hospital das Clínicas University of São Paulo Medical School Brazil
6 shared publicationsLuiz Aparecido Bortolotto
Instituto do Coração (Incor) University of São Paulo Medical School – Hypertension Unit Brazil
5 shared publicationsClaudia Maia Memória
Department of Neurology, Hospital das Clínicas University of São Paulo Medical School Brazil
4 shared publicationsEdson Bor-Seng-Shu
Department of Neurology, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil
4 shared publicationsHenrique Cotchi Simbo Muela
Instituto do Coração (Incor) University of São Paulo Medical School – Hypertension Unit Brazil
4 shared publicationsNatalia Cristina Moraes
Department of Neurology, Hospital das Clínicas University of São Paulo Medical School Brazil
4 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by Publicacoes Cientificas de Acesso Aberto e Editora LTDA in Brazilian Journal of Case Reports
- Vol. 5 (1) , bjcr57
Ischemic Stroke in a Child with Sickle Cell Anemia, Patent Foramen Ovale and Moya-Moya Syndrome: The Challenges of Implementing a Secondary Prevention Strategy
Strokes, traditionally regarded as conditions affecting adults, can also occur in the pediatric population, where their rarity often delays diagnosis. This report describes the case of a seven-year-old boy with sickle cell anemia who was admitted with left-sided motor deficits. The patient had been febrile and recumbent the previous day. Laboratory tests revealed severe anemia (hemoglobin 6.7 g/dL). During hospitalization, a transthoracic echocardiogram identified a patent foramen ovale (PFO) with left-to-right atrial flow and dilation of the left heart chambers. Brain imaging revealed lesions in the vascular border zones, while cerebral angiography confirmed severe stenosis in the internal carotid artery and a Moyamoya pattern. Following an etiological investigation, the symptoms were attributed to an ischemic stroke. Empirical antimicrobial therapy, blood transfusions, and antiplatelet therapy were initiated. Two potential mechanisms for the stroke were identified: PFO and Moya-Moya syndrome (MMS). The coexistence of these rare conditions in a pediatric patient presented unique diagnostic and therapeutic challenges. MMS was considered the primary cause of the stroke due to characteristic imaging findings and the patient’s history of sickle cell anemia. This case highlights the complexities of managing pediatric strokes with dual pathologies and the importance of a multidisciplinary approach. It advances clinical understanding by demonstrating how PFO complicates secondary prevention in MMS and emphasizes the need for individualized treatment strategies and long-term follow-up to optimize outcomes.
- 1 January 2025
- Published by Publicacoes Cientificas de Acesso Aberto e Editora LTDA in Brazilian Journal of Case Reports
- Vol. 5 (1) , bjcr57
Open AccessIschemic Stroke in a Child with Sickle Cell Anemia, Patent Foramen Ovale and Moya-Moya Syndrome: The Challenges of Implementing a Secondary Prevention Strategy
Strokes, traditionally regarded as conditions affecting adults, can also occur in the pediatric population, where their rarity often delays diagnosis. This report describes the case of a seven-year-old boy with sickle cell anemia who was admitted with left-sided motor deficits. The patient had been febrile and recumbent the previous day. Laboratory tests revealed severe anemia (hemoglobin 6.7 g/dL). During hospitalization, a transthoracic echocardiogram identified a patent foramen ovale (PFO) with left-to-right atrial flow and dilation of the left heart chambers. Brain imaging revealed lesions in the vascular border zones, while cerebral angiography confirmed severe stenosis in the internal carotid artery and a Moyamoya pattern. Following an etiological investigation, the symptoms were attributed to an ischemic stroke. Empirical antimicrobial therapy, blood transfusions, and antiplatelet therapy were initiated. Two potential mechanisms for the stroke were identified: PFO and Moya-Moya syndrome (MMS). The coexistence of these rare conditions in a pediatric patient presented unique diagnostic and therapeutic challenges. MMS was considered the primary cause of the stroke due to characteristic imaging findings and the patient’s history of sickle cell anemia. This case highlights the complexities of managing pediatric strokes with dual pathologies and the importance of a multidisciplinary approach. It advances clinical understanding by demonstrating how PFO complicates secondary prevention in MMS and emphasizes the need for individualized treatment strategies and long-term follow-up to optimize outcomes.
- 12 November 2024
- Published by Wiley in Clinical Physiology and Functional Imaging
- Vol. 45 (1)
Correlation between antihypertensive drugs and cerebral hemodynamic parameters: insights from observational findings using transcranial Doppler
Background: Antihypertensives (AHD) can influence cerebral autoregulation (CA) and attenuate hypertrophic concentric remodelling of arterioles. The aim of this study was to examine the associations between AHD, CA and structural and functional properties of cerebral arteries.Methods: In this observational, cross‐sectional study 115 volunteers were divided in group 1 (non‐hypertensive) [n = 30]; group 2 (hypertensive with systolic blood pressure [SBP] < 140 and diastolic blood pressure [DBP] < 90 mmHg) [n = 54]; group 3 (hypertensive with SBP ≥ 140 or DBP ≥ 90 mmHg) [n = 31] and simultaneous measurements of systemic blood pressure (BP) and middle cerebral artery blood flow velocity (CBFV) were obtained from digital plethysmography and transcranial Doppler. Beat‐to‐beat, critical closing pressure (CrCP), resistance‐area product (RAP) and autoregulation index (ARI) values were extracted by linear regression analysis of instantaneous BP and CBFV waveforms using computerised analysis. Pulsatility index (PI) was calculated and CO2 reactivity was assessed by the breath‐holding test.Results: Despite their higher RAP (1.7 [±0.7], p < 0.001) compared to groups 1 and 2, uncontrolled hypertensive using diuretics (p = 0.047) and α2‐agonists (p = 0.009) had significantly lower PI. Impaired CO2 reactivity was common between the two hypertensive groups (p = 0.008), however ARI, CrCP and CBFV did not differ between them and non‐hypertensive individuals and also did not correlate with any AHD used.Conclusions: Unlike the RAP, PI does not seem to reflect the real cerebrovascular resistence resulting from chronic arterial remodelling. Despite impaired CO2 reactivity, hypertensive have arterial tonus and CA comparable to non‐hypertensive. Experimental studies involving an untreated hypertensive control group are required to robustly make definitive conclusions about these questions.
- 12 November 2024
- Published by Wiley in Clinical Physiology and Functional Imaging
- Vol. 45 (1)
Correlation between antihypertensive drugs and cerebral hemodynamic parameters: insights from observational findings using transcranial Doppler
Background: Antihypertensives (AHD) can influence cerebral autoregulation (CA) and attenuate hypertrophic concentric remodelling of arterioles. The aim of this study was to examine the associations between AHD, CA and structural and functional properties of cerebral arteries.Methods: In this observational, cross‐sectional study 115 volunteers were divided in group 1 (non‐hypertensive) [n = 30]; group 2 (hypertensive with systolic blood pressure [SBP] < 140 and diastolic blood pressure [DBP] < 90 mmHg) [n = 54]; group 3 (hypertensive with SBP ≥ 140 or DBP ≥ 90 mmHg) [n = 31] and simultaneous measurements of systemic blood pressure (BP) and middle cerebral artery blood flow velocity (CBFV) were obtained from digital plethysmography and transcranial Doppler. Beat‐to‐beat, critical closing pressure (CrCP), resistance‐area product (RAP) and autoregulation index (ARI) values were extracted by linear regression analysis of instantaneous BP and CBFV waveforms using computerised analysis. Pulsatility index (PI) was calculated and CO2 reactivity was assessed by the breath‐holding test.Results: Despite their higher RAP (1.7 [±0.7], p < 0.001) compared to groups 1 and 2, uncontrolled hypertensive using diuretics (p = 0.047) and α2‐agonists (p = 0.009) had significantly lower PI. Impaired CO2 reactivity was common between the two hypertensive groups (p = 0.008), however ARI, CrCP and CBFV did not differ between them and non‐hypertensive individuals and also did not correlate with any AHD used.Conclusions: Unlike the RAP, PI does not seem to reflect the real cerebrovascular resistence resulting from chronic arterial remodelling. Despite impaired CO2 reactivity, hypertensive have arterial tonus and CA comparable to non‐hypertensive. Experimental studies involving an untreated hypertensive control group are required to robustly make definitive conclusions about these questions.
- 4 October 2024
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 39 (1) , 15-21
Angiotensin-converting enzyme inhibitors: a therapeutic option for controlling blood pressure associated with delayed cognitive processing speed
Antihypertensive treatment (AT) is essential for preventing hypertension-related cognitive decline. The goals of this observational study were to compare cognitive performance (CP) between non-hypertensive (NH) volunteers and hypertensive patients and to evaluate the correlation between CP and antihypertensive drugs (AHD). Three groups were constituted: NH (n = 30) [group 1], hypertensive with systolic blood pressure (SBP) < 140 mmHg and diastolic blood pressure (DBP) < 90 mmHg (n = 54) [group 2] and hypertensive with SBP ≥ 140 or DBP ≥ 90 (n = 31) [group 3]. To analyze the cognitive domains, a neuropsychological battery was applied and the raw performance values in these tests were transformed into z-scores. The domain was considered impaired if it presented a z-score below −1.5 SD. Compared to group 1, both groups of hypertensive were older (51 [ ± 12] years) and showed a worse CP in episodic memory (p = 0.014), language (p = 0.003) and processing speed (PS) [p = 0.05]. Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) were the most used AHD (46.3%, p = 0.01 [group 2] and 64.5%, p = 0.005 [group 3]) and showed correlations with PS. Linear regression models revealed a negative association of PS with the use of ACEi (β = −0.230, p = 0.004), but not with the use of ARB (β = 0.208, p = 0.008). The effect of AT on cognition appears to go beyond the search for lower blood pressure targets and also includes the mechanism of action of AHD on the brain, so that additional benefits may possibly be achieved with simple adaptations in the treatment regimen, particularly in patients without clinically manifest cognitive impairment.
- 4 October 2024
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 39 (1) , 15-21
Angiotensin-converting enzyme inhibitors: a therapeutic option for controlling blood pressure associated with delayed cognitive processing speed
Antihypertensive treatment (AT) is essential for preventing hypertension-related cognitive decline. The goals of this observational study were to compare cognitive performance (CP) between non-hypertensive (NH) volunteers and hypertensive patients and to evaluate the correlation between CP and antihypertensive drugs (AHD). Three groups were constituted: NH (n = 30) [group 1], hypertensive with systolic blood pressure (SBP) < 140 mmHg and diastolic blood pressure (DBP) < 90 mmHg (n = 54) [group 2] and hypertensive with SBP ≥ 140 or DBP ≥ 90 (n = 31) [group 3]. To analyze the cognitive domains, a neuropsychological battery was applied and the raw performance values in these tests were transformed into z-scores. The domain was considered impaired if it presented a z-score below −1.5 SD. Compared to group 1, both groups of hypertensive were older (51 [ ± 12] years) and showed a worse CP in episodic memory (p = 0.014), language (p = 0.003) and processing speed (PS) [p = 0.05]. Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) were the most used AHD (46.3%, p = 0.01 [group 2] and 64.5%, p = 0.005 [group 3]) and showed correlations with PS. Linear regression models revealed a negative association of PS with the use of ACEi (β = −0.230, p = 0.004), but not with the use of ARB (β = 0.208, p = 0.008). The effect of AT on cognition appears to go beyond the search for lower blood pressure targets and also includes the mechanism of action of AHD on the brain, so that additional benefits may possibly be achieved with simple adaptations in the treatment regimen, particularly in patients without clinically manifest cognitive impairment.
- 17 December 2023
- Published by Springer Nature
- p. 245-255
Comparison of Cerebral Autoregulation in Patients with Mild and Severe Arterial Hypertension
- 17 December 2023
- Published by Springer Nature
- p. 245-255
Comparison of Cerebral Autoregulation in Patients with Mild and Severe Arterial Hypertension
- Open Access
- 10 November 2023
- Published by Elsevier in Cerebral Circulation - Cognition and Behavior
- Vol. 5, 100191
Measurement of resistance-area product by transcranial Doppler: An alternative tool for cognitive screening in hypertensive on drug treatment?
- 10 November 2023
- Published by Elsevier in Cerebral Circulation - Cognition and Behavior
- Vol. 5, 100191
Open AccessMeasurement of resistance-area product by transcranial Doppler: An alternative tool for cognitive screening in hypertensive on drug treatment?
- Open Access
- 23 December 2022
- Published by Wiley
Measurement of resistance-area product by transcranial Doppler: a reliable marker of preclinical cognitive decline in hypertensive patients on drug treatment
Arterial hypertrophy and remodeling are adaptive responses present in SAH that can result in silent ischemia and neurodegeneration, compromising brain connections and cognitive abilities. However, antihypertensives can minimize these histological changes. We try to assess whether cerebrovascular hemodynamic parameters, representative of these histological adaptations, can identify cognitive impairment in a preclinical stage in chronic hypertensive on drug treatment. Three groups of patients without cognitive complaints were prospectively compared: hypertensive under treatment with systolic blood pressure (SBP) < 140 and diastolic blood pressure (DBP) < 90 mmHg (n=54), hypertensive under treatment with SBP > 140 or DBP >90 mmHg (n=31) and volunteers normotensive (n=30). Simultaneous measurements of systemic BP and middle cerebral artery (MCA) blood flow velocity were obtained from digital plethysmography and Transcranial Doppler. For the cognitive assessment, the Mini Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA) and a broad neuropsychological battery were applied. In relation to normotensive, uncontrolled hypertensive were older (51 ± 12 years), had greater resistance-area product (RAP 1.7 [±0.7] vs. 1.2 [±0.2], p< 0.001), but did not differ in relation to the pulsatility indices (p=0.361). There was a negative correlation between RAP, episodic memory (r = -0.277, p=0.004) and cognitive processing speed (r = -0.319, p=0.001). In chronic hypertensive using antihypertensive, the RAP is a reliable marker of preclinical cognitive decline in specific domains, as it is less influenced by the direct action of these drugs, and should be further explored as an alternative tool for screening for cognitive impairment in these individuals.
- 23 December 2022
- Published by Wiley
Open AccessMeasurement of resistance-area product by transcranial Doppler: a reliable marker of preclinical cognitive decline in hypertensive patients on drug treatment
Arterial hypertrophy and remodeling are adaptive responses present in SAH that can result in silent ischemia and neurodegeneration, compromising brain connections and cognitive abilities. However, antihypertensives can minimize these histological changes. We try to assess whether cerebrovascular hemodynamic parameters, representative of these histological adaptations, can identify cognitive impairment in a preclinical stage in chronic hypertensive on drug treatment. Three groups of patients without cognitive complaints were prospectively compared: hypertensive under treatment with systolic blood pressure (SBP) < 140 and diastolic blood pressure (DBP) < 90 mmHg (n=54), hypertensive under treatment with SBP > 140 or DBP >90 mmHg (n=31) and volunteers normotensive (n=30). Simultaneous measurements of systemic BP and middle cerebral artery (MCA) blood flow velocity were obtained from digital plethysmography and Transcranial Doppler. For the cognitive assessment, the Mini Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA) and a broad neuropsychological battery were applied. In relation to normotensive, uncontrolled hypertensive were older (51 ± 12 years), had greater resistance-area product (RAP 1.7 [±0.7] vs. 1.2 [±0.2], p< 0.001), but did not differ in relation to the pulsatility indices (p=0.361). There was a negative correlation between RAP, episodic memory (r = -0.277, p=0.004) and cognitive processing speed (r = -0.319, p=0.001). In chronic hypertensive using antihypertensive, the RAP is a reliable marker of preclinical cognitive decline in specific domains, as it is less influenced by the direct action of these drugs, and should be further explored as an alternative tool for screening for cognitive impairment in these individuals.
- Open Access
- 15 December 2022
- Published by Springer Nature in Research Square
The influence of antihypertensive drugs on hemodynamic parameters of cerebral arteries assessed by transcranial Doppler
Arterial hypertrophy and remodeling are adaptive responses present in the systemic arterial hypertension (SAH). As a result, antihypertensive drugs (AHD) begin to play an important role in controlling the cerebral blood flow. To evaluate the influence of AHD on cerebral hemodynamic parameters (CHP). Three groups of patients were compared: hypertensive with systolic blood pressure (SBP) < 140 and diastolic blood pressure (DBP) < 90 mmHg (n = 54), hypertensive with SBP > 140 or DBP > 90 mmHg (n = 31) and normotensive (n = 30). Simultaneous measurements of systemic blood pressure (BP) and middle cerebral artery (MCA) blood flow velocity (CBFV) were obtained from digital plethysmography and Transcranial Doppler. The use of diuretics (p = 0.047) and α-agonists (p = 0.009) reduced the pulsatility index (PI) among uncontrolled hypertensives, but did not change their arterial stiffness in relation to the others groups (RAP 1.7 [± 0.7], p < 0.001). There was no correlation between ADH and other CHP, although the RAP of controlled hypertensives was comparable to that of normotensives. Among uncontrolled hypertensives, the use of AHD with direct vasodilating action actively reduces PI, so it does not reflect a real cerebrovascular resistance of adaptive histological changes. This effect seems to be smaller among controlled hypertensives, due to their lower arterial stiffness, probably resulting from the attenuation of these changes.
- 15 December 2022
- Published by Springer Nature in Research Square
Open AccessThe influence of antihypertensive drugs on hemodynamic parameters of cerebral arteries assessed by transcranial Doppler
Arterial hypertrophy and remodeling are adaptive responses present in the systemic arterial hypertension (SAH). As a result, antihypertensive drugs (AHD) begin to play an important role in controlling the cerebral blood flow. To evaluate the influence of AHD on cerebral hemodynamic parameters (CHP). Three groups of patients were compared: hypertensive with systolic blood pressure (SBP) < 140 and diastolic blood pressure (DBP) < 90 mmHg (n = 54), hypertensive with SBP > 140 or DBP > 90 mmHg (n = 31) and normotensive (n = 30). Simultaneous measurements of systemic blood pressure (BP) and middle cerebral artery (MCA) blood flow velocity (CBFV) were obtained from digital plethysmography and Transcranial Doppler. The use of diuretics (p = 0.047) and α-agonists (p = 0.009) reduced the pulsatility index (PI) among uncontrolled hypertensives, but did not change their arterial stiffness in relation to the others groups (RAP 1.7 [± 0.7], p < 0.001). There was no correlation between ADH and other CHP, although the RAP of controlled hypertensives was comparable to that of normotensives. Among uncontrolled hypertensives, the use of AHD with direct vasodilating action actively reduces PI, so it does not reflect a real cerebrovascular resistance of adaptive histological changes. This effect seems to be smaller among controlled hypertensives, due to their lower arterial stiffness, probably resulting from the attenuation of these changes.
- Open Access
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Anais da Academia Brasileira de Ciências
- Vol. 94 (suppl 1) , e20201141
Soil-chronosequence and Quaternary landscape evolution at the marine terraces of Harmony Point, Nelson Island, Maritime Antarctica
This study characterized the physical, chemical, macro- and micromorphological soil properties from three successive marine terrace levels from Harmony Point (Nelson Island, Maritime Antarctica) in order to understand the pedological signatures of Quaternary coastal landscape evolution of Maritime Antarctica. Soils were sampled on the Late Holocene beach (current beach) and Mid Holocene marine terraces higher up, at 3, 8, and 12 m a.s.l. At the lower levels, the predominant soils were Gelorthents, whereas Haplogelepts dominate the higher terraces. Soil properties are mostly influenced by parent material and faunal activity, in which cryoclastic (thermal weathering) and phosphatization are the main soil-forming processes. Soils from the upper levels are more developed, deeper with reddish colors, granular structures and incipient formation B horizon. These horizonation features highlight that soils vary according with age of glacier-isostatic terrace uplift, representing a Quaternary soil chronosequence. All marine terrace levels are Ornithogenic soils, at varying degrees. However, the presence of old bird nesting sites for long periods led to formation of phosphatic horizons, stable Fe-phosphate minerals and abundant vegetation in the highest terraces of this part of Maritime Antarctica.
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Anais da Academia Brasileira de Ciências
- Vol. 94 (suppl 1) , e20201141
Open AccessSoil-chronosequence and Quaternary landscape evolution at the marine terraces of Harmony Point, Nelson Island, Maritime Antarctica
This study characterized the physical, chemical, macro- and micromorphological soil properties from three successive marine terrace levels from Harmony Point (Nelson Island, Maritime Antarctica) in order to understand the pedological signatures of Quaternary coastal landscape evolution of Maritime Antarctica. Soils were sampled on the Late Holocene beach (current beach) and Mid Holocene marine terraces higher up, at 3, 8, and 12 m a.s.l. At the lower levels, the predominant soils were Gelorthents, whereas Haplogelepts dominate the higher terraces. Soil properties are mostly influenced by parent material and faunal activity, in which cryoclastic (thermal weathering) and phosphatization are the main soil-forming processes. Soils from the upper levels are more developed, deeper with reddish colors, granular structures and incipient formation B horizon. These horizonation features highlight that soils vary according with age of glacier-isostatic terrace uplift, representing a Quaternary soil chronosequence. All marine terrace levels are Ornithogenic soils, at varying degrees. However, the presence of old bird nesting sites for long periods led to formation of phosphatic horizons, stable Fe-phosphate minerals and abundant vegetation in the highest terraces of this part of Maritime Antarctica.
- Open Access
- 23 September 2020
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 22 (11) , 2114-2120
Evaluation of cerebral autoregulation performance in patients with arterial hypertension on drug treatment
Cerebral autoregulation (AR) keeps cerebral blood flow constant despite fluctuations in systemic arterial pressure. The final common AR pathway is made up of vasomotor adjustments of cerebrovascular resistance mediated by arterioles. Structural and functional changes in the arteriolar wall arise with age and systemic arterial hypertension. This study evaluated whether AR is impaired in hypertensive patients and whether this impairment differs with disease control. Three groups of patients were prospectively compared: hypertensive patients under treatment with systolic blood pressure (SBP) 90 mm Hg (n = 31), and normotensive volunteers (n = 30). Simultaneous measurements of cerebral blood flow velocity (CBFV) and BP were obtained by digital plethysmography and transcranial Doppler, and the AR index (ARI) was defined according to the step response to spontaneous fluctuations in BP. Compared to the uncontrolled hypertension, the normotensive individuals were younger (age 43.42 ± 11.14, P < .05) and had a lower resistance‐area product (1.17 ± 0.24, P < .05), although age and greater arteriolar stiffness did not affect the CBFV mean of hypertensive patients, whether controlled or uncontrolled (62.85 × 58.49 × 58.30 cm/s, P = .29), most likely because their ARIs were not compromised (5.54 × 5.91 × 5.88, P = .6). Hypertensive patients under treatment, regardless of their BP control, have intact AR capacity.
- 23 September 2020
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 22 (11) , 2114-2120
Open AccessEvaluation of cerebral autoregulation performance in patients with arterial hypertension on drug treatment
Cerebral autoregulation (AR) keeps cerebral blood flow constant despite fluctuations in systemic arterial pressure. The final common AR pathway is made up of vasomotor adjustments of cerebrovascular resistance mediated by arterioles. Structural and functional changes in the arteriolar wall arise with age and systemic arterial hypertension. This study evaluated whether AR is impaired in hypertensive patients and whether this impairment differs with disease control. Three groups of patients were prospectively compared: hypertensive patients under treatment with systolic blood pressure (SBP) 90 mm Hg (n = 31), and normotensive volunteers (n = 30). Simultaneous measurements of cerebral blood flow velocity (CBFV) and BP were obtained by digital plethysmography and transcranial Doppler, and the AR index (ARI) was defined according to the step response to spontaneous fluctuations in BP. Compared to the uncontrolled hypertension, the normotensive individuals were younger (age 43.42 ± 11.14, P < .05) and had a lower resistance‐area product (1.17 ± 0.24, P < .05), although age and greater arteriolar stiffness did not affect the CBFV mean of hypertensive patients, whether controlled or uncontrolled (62.85 × 58.49 × 58.30 cm/s, P = .29), most likely because their ARIs were not compromised (5.54 × 5.91 × 5.88, P = .6). Hypertensive patients under treatment, regardless of their BP control, have intact AR capacity.
- Open Access
- 1 July 2020
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 78 (7) , 412-418
Systemic arterial hypertension and cognition in adults: effects on executive functioning
Background: Central nervous system changes associated to systemic arterial hypertension (SAH) are progressive and may cause negative effects on cognitive performance. The objective of this study was to investigate the relation between SAH and the components of executive functions (EF), inhibitory control (IC), updating and shifting, comparing a control group (without SAH) to patients with SAH, in two levels of severity. Methods: The protocol included the following tests to evaluate EF components: T.O.V.A. Test (IC), Backward Digit Span from Wechsler Adults Intelligence Scale (WAIS-III), Phonemic and Semantic Verbal Fluency (updating), and Trail Making Test Part B (shifting). Results: A total of 204 participants was included: 56 from the Control Group (CG), 87 SAH stage 1, and 61 SAH stage 2. The groups were not different for age (52.37±12.29) and education (10.98±4.06). As to controlled blood pressure (BP), duration of hypertension treatment and number of drugs, the SAH 2 group had a worse BP control, longer duration of hypertension treatment and use of more drugs when compared to the SAH 1. The findings revealed that patients with more severe hypertension presented worse performance in updating (Backward Digit Span, phonemic and semantics VF) and shifting (Trail Making Test Part B). Conclusion: The results suggest that patients with SAH have a significant impairment in EF, more specifically in updating and shifting. Besides that, such damage may be directly proportional to the severity of SAH. It is suggested that future studies include neuroimaging exams to exclude possible cerebrovascular diseases.
- 1 July 2020
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 78 (7) , 412-418
Open AccessSystemic arterial hypertension and cognition in adults: effects on executive functioning
Background: Central nervous system changes associated to systemic arterial hypertension (SAH) are progressive and may cause negative effects on cognitive performance. The objective of this study was to investigate the relation between SAH and the components of executive functions (EF), inhibitory control (IC), updating and shifting, comparing a control group (without SAH) to patients with SAH, in two levels of severity. Methods: The protocol included the following tests to evaluate EF components: T.O.V.A. Test (IC), Backward Digit Span from Wechsler Adults Intelligence Scale (WAIS-III), Phonemic and Semantic Verbal Fluency (updating), and Trail Making Test Part B (shifting). Results: A total of 204 participants was included: 56 from the Control Group (CG), 87 SAH stage 1, and 61 SAH stage 2. The groups were not different for age (52.37±12.29) and education (10.98±4.06). As to controlled blood pressure (BP), duration of hypertension treatment and number of drugs, the SAH 2 group had a worse BP control, longer duration of hypertension treatment and use of more drugs when compared to the SAH 1. The findings revealed that patients with more severe hypertension presented worse performance in updating (Backward Digit Span, phonemic and semantics VF) and shifting (Trail Making Test Part B). Conclusion: The results suggest that patients with SAH have a significant impairment in EF, more specifically in updating and shifting. Besides that, such damage may be directly proportional to the severity of SAH. It is suggested that future studies include neuroimaging exams to exclude possible cerebrovascular diseases.